In this issue:
Decreasing death rates in RA patients
Belimumab: good tolerability in SLE
Central pain in RA
Endothelin receptor antagonism in SSc
Rituximab promising in diffuse cutaneous SSc
Strontium ranelate benefits knee OA . . . . . . but questions remain
Periodonta
Please login below to download this issue (PDF)